|
|
||||||||
The Journal of Immunology, Vol 142, Issue 9 3151-3157, Copyright © 1989 by American Association of Immunologists
ARTICLES |
H Fischer, M Dohlsten, M Lindvall, HO Sjogren and R Carlsson
Department of Tumor Immunology, University of Lund, Sweden.
Staphylococcal enterotoxin A (SEA) is a potent polyclonal T cell activator. Its activating effect is entirely dependent upon its binding to accessory cells. Monocytes, B cells, and B lymphomas can bind SEA and support activation of T cells. We have earlier found that Raji cells are particularly efficient as accessory cells for SEA-induced T cell proliferation. In the present investigation we have used this cell line for the isolation and characterization of the membrane molecule to which SEA binds. Flow cytometric analysis of cells dually stained with SEA and anti-HLA-DR mAb showed that the amount of bound SEA was proportional to the HLA-DR expression. Electrophoresis of detergent extracts of Raji cells revealed one distinct SEA-binding band with a Mr of 60 to 65 kDa. This band had the same electrophoretic mobility as the MHC class II molecules. A mAb (G8) with the ability to block SEA binding to Raji cells was established. This mAb was shown to bind to the HLA-DR molecule. Both the G8 mAb and an anti-HLA-DR mAb 9-49 inhibited SEA binding to accessory cells and also inhibited SEA- induced, but not PHA-induced, T cell proliferation and production of IL- 2. Immunoprecipitation with specific anti-HLA-DR and anti-HLA-DQ mAb demonstrated that SEA binds to the HLA-DR molecule but not to the HLA- DQ molecule. Binding SEA to Raji cells followed by cross-linking and detergent solubilization of cell membranes, electrophoresis, and Western blotting resulted in two SEA-containing bands corresponding to a Mr of 90 and 105 kDa, respectively. Both these bands also contained the HLA-DR molecule and their appearance could be blocked by preincubation of the Raji cells with the G8 mAb. Collectively the results show that the HLA-DR molecule is the main functional molecule for binding of SEA to accessory cells and that this binding of SEA to HLA-DR is a necessary requirement for SEA-induced T cell activation.
This article has been cited by other articles:
![]() |
J. D. Cheng, J. S. Babb, C. Langer, S. Aamdal, F. Robert, L. R. Engelhardt, O. Fernberg, J. Schiller, G. Forsberg, R. K. Alpaugh, et al. Individualized Patient Dosing in Phase I Clinical Trials: The Role of Escalation With Overdose Control in PNU-214936 J. Clin. Oncol., February 15, 2004; 22(4): 602 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Messmer, R. Ignatius, C. Santisteban, R. M. Steinman, and M. Pope The Decreased Replicative Capacity of Simian Immunodeficiency Virus SIVmac239Delta nef Is Manifest in Cultures of Immature Dendritic Cells and T Cells J. Virol., March 1, 2000; 74(5): 2406 - 2413. [Abstract] [Full Text] |
||||
![]() |
M. A. Coppola, E. Flano, P. Nguyen, C. L. Hardy, R. D. Cardin, N. Shastri, D. L. Woodland, and M. A. Blackman Apparent MHC-Independent Stimulation of CD8+ T Cells In Vivo During Latent Murine Gammaherpesvirus Infection J. Immunol., August 1, 1999; 163(3): 1481 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Redpath, S. M. Alam, C. M. Lin, A. M. O'Rourke, and N. R. J. Gascoigne Cutting Edge: Trimolecular Interaction of TCR with MHC Class II and Bacterial Superantigen Shows a Similar Affinity to MHC:Peptide Ligands J. Immunol., July 1, 1999; 163(1): 6 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Li, R. E. Tiedemann, S. L. Moffat, and J. D. Fraser The Superantigen Streptococcal Pyrogenic Exotoxin C (SPE-C) Exhibits a Novel Mode of Action J. Exp. Med., August 4, 1997; 186(3): 375 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Tripp, A. M. Hamilton-Easton, R. D. Cardin, P. Nguyen, F. G. Behm, D. L. Woodland, P. C. Doherty, and M. A. Blackman Pathogenesis of an Infectious Mononucleosis-like Disease Induced by a Murine gamma -Herpesvirus: Role for a Viral Superantigen? J. Exp. Med., May 5, 1997; 185(9): 1641 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gidlof, M. Dohlsten, P. Lando, T. Kalland, C. Sundstrom, and T. H. Totterman A Superantigen-Antibody Fusion Protein for T-Cell Immunotherapy of Human B-Lineage Malignancies Blood, March 15, 1997; 89(6): 2089 - 2097. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Niedergang, A.ès Hémar, C. R. A. Hewitt, M. J. Owen, A. Dautry-Varsat, and A.és Alcover The Staphylococcus aureus Enterotoxin B Superantigen Induces Specific T Cell Receptor Down-regulation by Increasing Its Internalization J. Biol. Chem., May 26, 1995; 270(21): 12839 - 12845. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hugin, M. Vacchio, and H. Morse 3rd A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice Science, April 19, 1991; 252(5004): 424 - 427. [Abstract] [PDF] |
||||
![]() |
J. Mollick, R. Cook, and R. Rich Class II MHC molecules are specific receptors for staphylococcus enterotoxin A Science, May 19, 1989; 244(4906): 817 - 820. [Abstract] [PDF] |
||||
![]() |
M.-T. Zilber, S. Gregory, R. Mallone, S. Deaglio, F. Malavasi, D. Charron, and C. Gelin CD38 expressed on human monocytes: A coaccessory molecule in the superantigen-induced proliferation PNAS, March 14, 2000; 97(6): 2840 - 2845. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |